Figure 35 displays a graph of the risk of dizziness across interventions. There were 17 different drug combinations, as well as placebo, that were associated with dizziness. The lowest risks were seen in DHE and prochlorperazine, while the highest risks were seen in methotrimeprazine and chlorpromazine.

Figure 35Risk of dizziness reported in acute migraine trials

From: Results

Cover of Acute Migraine Treatment in Emergency Settings
Acute Migraine Treatment in Emergency Settings [Internet].
Comparative Effectiveness Reviews, No. 84.
Sumamo Schellenberg E, Dryden DM, Pasichnyk D, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.